Explanatory note
(This note is not part of the Order)
This Order amends the Medicines (Advisory Board on the Registration of Homoeopathic Products) Order 1995, to extend the functions of the Advisory Board on the Registration of Homoeopathic Products to include the provision of advice on the safety, quality and efficacy of homoeopathic medicinal products which have a product licence of right, or national homoeopathic products which have a marketing authorisation or in respect of which an application for such an authorisation is made. A national homoeopathic product is a homoeopathic medicinal product which is not eligible for the procedure for registration under the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994f1 and which is for the relief or treatment of minor symptoms or conditions.
A full regulatory impact assessment has not been produced for this instrument as it has no impact on the costs of business.
Annotations
Footnotes
- f1
-
S.I. 1994/105, amended by S.I.2005/2753; there are other amending instruments but none is relevant.